Header

UZH-Logo

Maintenance Infos

Welcome to Zurich Open Repository and Archive

The tumour microenvironment and immune milieu of cholangiocarcinoma.
Fabris, Luca; Perugorria, María J; Mertens, Joachim; Björkström, Niklas K; Cramer, Thorsten; Lleo, Ana; Solinas, Antonio; Sänger, Hanna; Lukacs-Kornek, Veronika; Moncsek, Anja; Siebenhüner, Alexander; Strazzabosco, Mario (2019).
Liver International, 39 Suppl:63-78. Item not available from this repository.
Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease.
Schreiner, Philipp; Yilmaz, Bahtiyar; Rossel, Jean-Benoît; Franc, Yannick; Misselwitz, Benjamin; Scharl, Michael; Zeitz, Jonas; Frei, Pascal; Greuter, Thomas; Vavricka, Stephan R; Pittet, Valérie; Siebenhüner, Alexander; Juillerat, Pascal; von Känel, Roland; Macpherson, Andrew J; Rogler, Gerhard; Biedermann, Luc; Swiss IBD Cohort Study Group, (2019).
United European Gastroenterology Journal, 7(6):767-781. Item not available from this repository.
Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study.
Schmid, S; Klingbiel, D; Aeppli, S; Britschgi, C; Gautschi, O; Pless, M; Rothschild, S; Wannesson, L; Janthur, W; Foerbs, D; Demmer, I; Jochum, W; Früh, M (2019).
Lung Cancer, 130:149-155. Item not available from this repository.
BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly.
Download PDF  'BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly'.
Preview
Frischknecht, Lukas; Britschgi, Christian; Galliker, Patricia; Christinat, Yann; Vichalkovski, Anton; Gstaiger, Matthias; Kovacs, Werner J; Krek, Wilhelm (2019).
Scientific Reports, 9:7779.
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).
Download PDF  'Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)'.
Preview
Curioni-Fontecedro, Alessandra; Perentes, Jean Yannis; Gelpke, Hans; Xyrafas, Alexandros; Bouchaab, Hasna; Mach, Nicolas; Matzinger, Oscar; Stojcheva, Nina; Frueh, Martin; Weder, Walter; Cathomas, Richard; Gargiulo, Piera; Bubendorf, Lukas; Pless, Miklos; Betticher, Daniel; Peters, Solange (2019).
British Journal of Cancer, 120(10):968-974.